Rheumatology Advance Access originally published online on December 23, 2008
Rheumatology 2009 48(3):323-324; doi:10.1093/rheumatology/ken447
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2008. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
Comment on: Amitriptyline in the treatment of fibromyalgia: a systematic review of its efficacy: reply
1Hospital de Sant Pau – Iberoamerican Cochrane Center, Barcelona, Spain
Correspondence to: G. Urrutia, Hospital de Sant Pau – Iberoamerican Cochrane Center, Sant Antoni M. Claret 171, Barcelona 08041, Spain. E-mail: gurrutia@santpau.es
| The first 10% of the full text of this article appears below. |
SIR, As Fontanelle and colleagues [1] point out, the results of our review [2] show that there is no objective evidence supporting the long-term efficacy of amitriptyline at a